90 related articles for article (PubMed ID: 9303433)
1. DNase I primary transcript is alternatively spliced in both normal and apoptotic cells: no evidence of up-regulation in apoptosis.
Liu QY; Ribecco M; Hou Y; Walker PR; Sikorska M
DNA Cell Biol; 1997 Aug; 16(8):911-8. PubMed ID: 9303433
[TBL] [Abstract][Full Text] [Related]
2. Identification and expression of deoxyribonuclease (DNase) I alternative transcripts in the rat.
Basnakian AG; Singh AB; Shah SV
Gene; 2002 May; 289(1-2):87-96. PubMed ID: 12036587
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel human tissue factor splice variant that is upregulated in tumor cells.
Chand HS; Ness SA; Kisiel W
Int J Cancer; 2006 Apr; 118(7):1713-20. PubMed ID: 16217771
[TBL] [Abstract][Full Text] [Related]
4. An alternatively spliced human insulin-like growth factor-I transcript with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide.
Chew SL; Lavender P; Clark AJ; Ross RJ
Endocrinology; 1995 May; 136(5):1939-44. PubMed ID: 7720641
[TBL] [Abstract][Full Text] [Related]
5. Cloning and functional expression of the luteinizing hormone receptor complementary deoxyribonucleic acid from the marmoset monkey testis: absence of sequences encoding exon 10 in other species.
Zhang FP; Rannikko AS; Manna PR; Fraser HM; Huhtaniemi IT
Endocrinology; 1997 Jun; 138(6):2481-90. PubMed ID: 9165039
[TBL] [Abstract][Full Text] [Related]
6. Multiple splicing events involved in regulation of human aromatase expression by a novel promoter, I.6.
Shozu M; Zhao Y; Bulun SE; Simpson ER
Endocrinology; 1998 Apr; 139(4):1610-7. PubMed ID: 9528941
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of c-fos pre-mRNA: contribution of the rates of synthesis and degradation to the copy number of each transcript isoform and detection of a truncated c-Fos immunoreactive species.
Jurado J; Fuentes-Almagro CA; Prieto-Alamo MJ; Pueyo C
BMC Mol Biol; 2007 Sep; 8():83. PubMed ID: 17888145
[TBL] [Abstract][Full Text] [Related]
8. Endonuclease G modulates the alternative splicing of deoxyribonuclease 1 mRNA in human CD4
Zhdanov DD; Gladilina YA; Pokrovsky VS; Grishin DV; Grachev VA; Orlova VS; Pokrovskaya MV; Alexandrova SS; Plyasova AA; Sokolov NN
Biochimie; 2019 Feb; 157():158-176. PubMed ID: 30521874
[TBL] [Abstract][Full Text] [Related]
9. Alternative splicing and differential expression of DT-diaphorase transcripts in human colon tumors and in peripheral mononuclear cells in response to mitomycin C treatment.
Yao KS; Godwin AK; Johnson C; O'Dwyer PJ
Cancer Res; 1996 Apr; 56(8):1731-6. PubMed ID: 8620484
[TBL] [Abstract][Full Text] [Related]
10. Characterization of human deoxyribonuclease I gene (DNASE1) promoters reveals the utilization of two transcription-starting exons and the involvement of Sp1 in its transcriptional regulation.
Kominato Y; Ueki M; Iida R; Kawai Y; Nakajima T; Makita C; Itoi M; Tajima Y; Kishi K; Yasuda T
FEBS J; 2006 Jul; 273(13):3094-105. PubMed ID: 16771825
[TBL] [Abstract][Full Text] [Related]
11. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
[TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of the mouse glucokinase gene locus and identification of distal liver-specific DNase I hypersensitive sites.
Postic C; Niswender KD; Decaux JF; Parsa R; Shelton KD; Gouhot B; Pettepher CC; Granner DK; Girard J; Magnuson MA
Genomics; 1995 Oct; 29(3):740-50. PubMed ID: 8575768
[TBL] [Abstract][Full Text] [Related]
13. Human transcription factor Sp3: genomic structure, identification of a processed pseudogene, and transcript analysis.
Moran KM; Crusio RH; Chan CH; Grekova MC; Richert JR
Gene; 2004 Oct; 341():235-47. PubMed ID: 15474306
[TBL] [Abstract][Full Text] [Related]
14. Possible regulation of telomerase activity by transcription and alternative splicing of telomerase reverse transcriptase in human melanoma.
Villa R; Porta CD; Folini M; Daidone MG; Zaffaroni N
J Invest Dermatol; 2001 Jun; 116(6):867-73. PubMed ID: 11407973
[TBL] [Abstract][Full Text] [Related]
15. A candidate chimeric mammalian mRNA transcript is derived from distinct chromosomes and is associated with nonconsensus splice junction motifs.
Zhang C; Xie Y; Martignetti JA; Yeo TT; Massa SM; Longo FM
DNA Cell Biol; 2003 May; 22(5):303-15. PubMed ID: 12941158
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms regulating the tumor-targeting potential of splice-activated gene expression.
Hayes GM; Dougherty ST; Davis PD; Dougherty GJ
Cancer Gene Ther; 2004 Dec; 11(12):797-807. PubMed ID: 15359288
[TBL] [Abstract][Full Text] [Related]
17. Structure of the mouse gonadotropin-releasing hormone receptor gene: variant transcripts generated by alternative processing.
Zhou W; Sealfon SC
DNA Cell Biol; 1994 Jun; 13(6):605-14. PubMed ID: 8024703
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of estrogen receptor mRNA and its alternatively spliced mRNAs in breast tumor cells and tissues.
Fasco MJ
Anal Biochem; 1997 Feb; 245(2):167-78. PubMed ID: 9056208
[TBL] [Abstract][Full Text] [Related]
19. Identification of an alternatively spliced transcript of human interleukin-4 lacking the sequence encoded by exon 2.
Sorg RV; Enczmann J; Sorg UR; Schneider EM; Wernet P
Exp Hematol; 1993 Apr; 21(4):560-3. PubMed ID: 8462665
[TBL] [Abstract][Full Text] [Related]
20. Genomic organization and structure of the 5'-flanking region of the TEX101 gene: alternative promoter usage and splicing generate transcript variants with distinct 5'-untranslated region.
Tsukamoto H; Takizawa T; Takamori K; Ogawa H; Araki Y
Mol Reprod Dev; 2007 Feb; 74(2):154-62. PubMed ID: 16941676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
